CRBP
Price
$9.80
Change
+$0.43 (+4.59%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
114.83M
ELAB
Price
$4.61
Change
+$2.99 (+184.57%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
8.42M
Interact to see
Advertisement

CRBP vs ELAB

Header iconCRBP vs ELAB Comparison
Open Charts CRBP vs ELABBanner chart's image
Corbus Pharmaceuticals Holdings
Price$9.80
Change+$0.43 (+4.59%)
Volume$681
Capitalization114.83M
PMGC Holdings
Price$4.61
Change+$2.99 (+184.57%)
Volume$100
Capitalization8.42M
CRBP vs ELAB Comparison Chart in %
Loading...
CRBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRBP vs. ELAB commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBP is a StrongBuy and ELAB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (CRBP: $9.37 vs. ELAB: $1.62)
Brand notoriety: CRBP and ELAB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBP: 59% vs. ELAB: 11%
Market capitalization -- CRBP: $114.83M vs. ELAB: $8.42M
CRBP [@Biotechnology] is valued at $114.83M. ELAB’s [@Biotechnology] market capitalization is $8.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBP’s FA Score shows that 0 FA rating(s) are green whileELAB’s FA Score has 1 green FA rating(s).

  • CRBP’s FA Score: 0 green, 5 red.
  • ELAB’s FA Score: 1 green, 4 red.
According to our system of comparison, CRBP is a better buy in the long-term than ELAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBP’s TA Score shows that 6 TA indicator(s) are bullish while ELAB’s TA Score has 4 bullish TA indicator(s).

  • CRBP’s TA Score: 6 bullish, 3 bearish.
  • ELAB’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CRBP is a better buy in the short-term than ELAB.

Price Growth

CRBP (@Biotechnology) experienced а -4.29% price change this week, while ELAB (@Biotechnology) price change was -31.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRBP($115M) has a higher market cap than ELAB($8.42M). CRBP YTD gains are higher at: -20.593 vs. ELAB (-89.894). ELAB has higher annual earnings (EBITDA): -4.37M vs. CRBP (-57.15M). CRBP has more cash in the bank: 117M vs. ELAB (6.31M). ELAB has less debt than CRBP: ELAB (103K) vs CRBP (2.46M). CRBP (0) and ELAB (0) have equivalent revenues.
CRBPELABCRBP / ELAB
Capitalization115M8.42M1,366%
EBITDA-57.15M-4.37M1,308%
Gain YTD-20.593-89.89423%
P/E RatioN/A0.05-
Revenue00-
Total Cash117M6.31M1,855%
Total Debt2.46M103K2,384%
FUNDAMENTALS RATINGS
CRBP: Fundamental Ratings
CRBP
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBPELAB
RSI
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
75%
Momentum
ODDS (%)
Bullish Trend 5 days ago
81%
Bearish Trend 5 days ago
90%
MACD
ODDS (%)
Bullish Trend 5 days ago
74%
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
85%
Bearish Trend 5 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 16 days ago
87%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 5 days ago
63%
Aroon
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMRK23.410.44
+1.92%
A-Mark Precious Metals
SYNA69.86-1.51
-2.12%
Synaptics
RBRK89.40-3.63
-3.90%
Rubrik
DEVS2.30-0.23
-9.09%
DevvStream Corp
ZJYL0.71-0.08
-10.59%
JIN MEDICAL INTERNATIONAL Ltd

CRBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBP has been loosely correlated with SKYE. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBP jumps, then SKYE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBP
1D Price
Change %
CRBP100%
-5.35%
SKYE - CRBP
47%
Loosely correlated
+0.57%
FBIO - CRBP
39%
Loosely correlated
+6.61%
APLS - CRBP
34%
Loosely correlated
-1.71%
STOK - CRBP
33%
Loosely correlated
-0.05%
ELAB - CRBP
30%
Poorly correlated
-13.37%
More

ELAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELAB has been loosely correlated with EPIX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ELAB jumps, then EPIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAB
1D Price
Change %
ELAB100%
-13.37%
EPIX - ELAB
35%
Loosely correlated
+2.13%
CRBP - ELAB
30%
Poorly correlated
-5.35%
LXRX - ELAB
21%
Poorly correlated
-4.35%
EDSA - ELAB
21%
Poorly correlated
-2.93%
CLNN - ELAB
21%
Poorly correlated
-1.66%
More